Germline CDH1 Mutations in Bilateral Lobular Carcinoma in Situ

Overview

Journal Br J Cancer

Specialty Oncology

Date 2013 Dec 25

PMID 24366306

Citations 36

Authors

C Petridis

I Shinomiya

K Kohut

P Gorman

M Caneppele

V Shah

M Troy

S E Pinder

A Hanby

I Tomlinson

R C Trembath

R Roylance

M A Simpson

E J Sawyer

Affiliations

Soon will be listed here.

Abstract

Background: Invasive lobular breast cancer (ILC) and lobular carcinoma in situ (LCIS) are characterised by loss of E-cadherin expression. However germline CDH1 mutations are rare in cases of ILC with no family history of hereditary diffuse gastric cancer (HDGC) and have not been described in women with LCIS.

Methods: We screened the CDH1 gene in 50 cases of bilateral LCIS/ILC using Sanger sequencing and MLPA.

Results: Sanger sequencing revealed four pathogenic germline mutations, including a novel splicing mutation (c.48+1G>A). The remaining three (c.1465insC, c.1942G>T, c.2398delC) have been previously described. All four cases had bilateral LCIS +/- ILC and no family history of gastric cancer.

Conclusion: CDH1 germline mutations have not been previously described in women with LCIS. We have shown that germline CDH1 mutations are associated with early onset of bilateral LCIS with or without ILC in women without a family history of gastric cancer. CDH1 mutation screening should be considered in women with early onset of bilateral LCIS/ILC with no family history of HDGC.

Citing Articles

Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.

Pareja F, Bhargava R, Borges V, Brogi E, Canas Marques R, Cardoso F NPJ Breast Cancer. 2025; 11(1):6.

PMID: 39856067 PMC: 11760369. DOI: 10.1038/s41523-025-00719-w.

CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.

Corso G, Marino E, Zanzottera C, Oliveira C, Bernard L, Macis D JAMA Netw Open. 2024; 7(4):e247862.

PMID: 38652475 PMC: 11040411. DOI: 10.1001/jamanetworkopen.2024.7862.

Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast Cancer.

Giunta E, Arrichiello G, Pappalardo A, Federico P, Petrillo A Cancer Treat Res. 2024; 188:89-104.

PMID: 38175343 DOI: 10.1007/978-3-031-33602-7_4.

Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.

Gamble L, McClelland P, Teke M, Samaranayake S, Juneau P, Famiglietti A NPJ Breast Cancer. 2023; 9(1):77.

PMID: 37758801 PMC: 10533560. DOI: 10.1038/s41523-023-00585-4.

DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?.

Timbres J, Kohut K, Caneppele M, Troy M, Schmidt M, Roylance R Cancers (Basel). 2023; 15(17).

PMID: 37686673 PMC: 10486708. DOI: 10.3390/cancers15174397.

References

Sung J, Malak S, Bajaj P, Alis R, Dershaw D, Morris E . Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 2011; 261(2):414-20. DOI: 10.1148/radiol.11110091. View

Fisher E, Land S, Fisher B, Mamounas E, Gilarski L, Wolmark N . Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004; 100(2):238-44. DOI: 10.1002/cncr.11883. View

Pharoah P, Guilford P, Caldas C . Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001; 121(6):1348-53. DOI: 10.1053/gast.2001.29611. View

Chuba P, Hamre M, Yap J, Severson R, Lucas D, Shamsa F . Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005; 23(24):5534-41. DOI: 10.1200/JCO.2005.04.038. View

Fitzgerald R, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V . Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010; 47(7):436-44. PMC: 2991043. DOI: 10.1136/jmg.2009.074237. View

Benusiglio P, Malka D, Rouleau E, de Pauw A, Buecher B, Nogues C . CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet. 2013; 50(7):486-9. DOI: 10.1136/jmedgenet-2012-101472. View

Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz J . The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat. 2004; 86(1):31-7. DOI: 10.1023/B:BREA.0000032921.10481.dc. View

Barber M, Murrell A, Ito Y, Maia A, Hyland S, Oliveira C . Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008; 216(3):295-306. DOI: 10.1002/path.2426. View

Rahman N, STONE J, Coleman G, Gusterson B, Seal S, Marossy A . Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer. 2000; 82(3):568-70. PMC: 2363330. DOI: 10.1054/bjoc.1999.0965. View

10.

Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel M . Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007; 44(11):726-31. PMC: 2752184. DOI: 10.1136/jmg.2007.051268. View

11.

Port E, Park A, Borgen P, Morris E, Montgomery L . Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol. 2007; 14(3):1051-7. DOI: 10.1245/s10434-006-9195-5. View

12.

Suriano G, Yew S, Ferreira P, Senz J, Kaurah P, Ford J . Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res. 2005; 11(15):5401-9. DOI: 10.1158/1078-0432.CCR-05-0247. View

13.

Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P . E-cadherin germline mutations in familial gastric cancer. Nature. 1998; 392(6674):402-5. DOI: 10.1038/32918. View

14.

Fisher B, Costantino J, Wickerham D, Cecchini R, Cronin W, Robidoux A . Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 2005; 97(22):1652-62. DOI: 10.1093/jnci/dji372. View

15.

Xie Z, Li L, Laquet C, Penault-Llorca F, Uhrhammer N, Xie X . Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer. 2011; 117(14):3112-7. DOI: 10.1002/cncr.25876. View

16.

. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012; 487(7407):330-7. PMC: 3401966. DOI: 10.1038/nature11252. View

17.

Brooks-Wilson A, Kaurah P, Suriano G, Leach S, Senz J, Grehan N . Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004; 41(7):508-17. PMC: 1735838. DOI: 10.1136/jmg.2004.018275. View

18.

Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart I . Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer. 2001; 92(3):404-8. DOI: 10.1002/ijc.1208. View

19.

Claus E, Risch N, Thompson W, Carter D . Relationship between breast histopathology and family history of breast cancer. Cancer. 1993; 71(1):147-53. DOI: 10.1002/1097-0142(19930101)71:1<147::aid-cncr2820710124>3.0.co;2-v. View

20.

Schrader K, Masciari S, Boyd N, Salamanca C, Senz J, Saunders D . Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet. 2010; 48(1):64-8. PMC: 3003879. DOI: 10.1136/jmg.2010.079814. View